Biofd&C expects third-quarter revenue to rise 7.7% as skin boosters drive growth
AI Summary- Biofd&C is expanding from plant-derived ingredients into finished skin booster products.
- 5.5 billion won is projected for third-quarter revenue, up 7.7% year over year.
- Biofd&C plans a 15 billion-won medical-device facility, with production targeted for 2028.